7 December 2017

Meet our CEO at JPM 2018 to discuss DAV132

Our CEO, Florence Séjourné will be attending JPM 2018 in January and we are looking forward to sharing all the recent news about DAV132 development that you may have seen in the press recently.  (...)

23 October 2017

Meet Da Volterra at BioEurope 2017

Da Volterra looks forward to attending BioEurope in Berlin from November 6 to 8th.  We would be happy to meet potential partners to discuss the many advances for our most advanced asset, DAV132. Please (...)

4 October 2017

Visit our Poster Showing Prevention of C. diff Induced Death at IDWeek 2017

Da Volterra will present a poster at IDWeek 2017 in San Diego in collaboration with our academic partner, IAME Reseach Center, demonstrating prevention of CDI induced death in hamsters with both moxifloxacin and (...)

7 September 2017

Da Volterra will Present in the C.diff Foundation Science Webinar September 14th, 2017

Da Volterra is looking forward to the C. diff Foundation Science Webinar, when our CSO, Jean de Gunzburg will present on September 14th, 2017 at 11AM EST. This webinar will offer insight into the science of (...)

9 June 2017

Meet Da Volterra at BIO2017 in San Diego

Our CEO, Florence Séjourné, is pleased to speak at BIO2017 during the Session: Partnerships that De-Risk Research & Development of Antimicrobial Products. Come to listen and learn more on Jun 21, (...)

15 May 2017

Da Volterra Presenting Protection of the Intestinal Microbiota at ASM Microbe 2017

Da Volterra is excited to give an Oral Presentation at ASM Microbe 2017, entitled DAV131A Prevents Alterations of the Intestinal Microbiota and Clostridium difficile Infection in Hamsters Treated with Moxifloxacin (...)

11 April 2017

Da Volterra Anticipating an Invigorating ECCMID 2017

ECCMID 2017 in Vienna, Austria is rapidly approaching the 22-25th of April and Da Volterra is looking forward to an invigorating congress and our CEO, Florence Séjourné will be present.  If (...)

8 March 2017

Da Volterra's CSO will present a webinar: Antibiotics & the Microbiome March 9th

Our CSO, Jean de Gunzburg will present a free webinar in combination with Oxford Global on Thursday, March 9th at 3 PM CET/ 2PM GMT.

The webinar will be entitled:

Antibiotics & the Microbiome

To (...)

6 March 2017

Da Volterra Attending BioSpring 2017 in Barcelona

Da Volterra will be attending BioSpring in Barcelona March 20-22 and we are looking forward to share our exciting progress for DAV132 development in the last year.  If you are interested to partner with Da (...)

9 January - 12 January 2017

Da Volterra Looking Forward to Attending JMP in January

Da Volterra will be represented at JP Morgan January 9-12 in San Francisco by our CEO, Florence Séjourné. We look forward to meeting many potential partners, both old and new during this stimulating (...)